_outcomes-of-first-line-pembrolizumab-monotherapy-for-pd-l1positive-metastatic-nsclc-preview-1.jpg "Outcomes of first-line pembrolizumab monotherapy for PD-L1–positive metastatic NSCLC from cpt code j9271 description pembrolizumab Video Screenshot Preview 1")
Gallery_outcomes-of-first-line-pembrolizumab-monotherapy-for-pd-l1positive-metastatic-nsclc-preview-3.jpg "Outcomes of first-line pembrolizumab monotherapy for PD-L1–positive metastatic NSCLC from cpt code j9271 description pembrolizumab Video Screenshot Preview 3")
Gallery_outcomes-of-first-line-pembrolizumab-monotherapy-for-pd-l1positive-metastatic-nsclc-preview-hqdefault.jpg "Outcomes of first-line pembrolizumab monotherapy for PD-L1–positive metastatic NSCLC from cpt code j9271 description pembrolizumab Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 7 minutes 31 seconds
👁 View: 634 times
Play Audio:👁 View: 634 times
Description:
Video Journal of Biomedicine
Video Journal of Biomedicine
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_outcomes-of-first-line-pembrolizumab-monotherapy-for-pd-l1positive-metastatic-nsclc.webp "Video Journal of Biomedicine")
⏲ 7 minutes 31 seconds 👁 634
_keynote-224-improving-hcc-outcomes-with-pembrolizumab.webp "OncLiveTV")
_pembrolizumab-for-ps2-patients-with-adv-nsclc-results-of-the-peps2-trial-bmic-067.webp "BeaconMedIC")
⏲ 4 minutes 13 seconds 👁 90
_keynote-966-pembrolizumab-gemcitabine-and-cisplatin-for-cca.webp "VJOncology")
_keytruda-pembrolizumab-drug-rx-information.webp "Global Drugs Rx Guide")
_keynote-667-pembrolizumab-plus-copdac-28-for-high-risk-chl-with-slow-early-response-to-oepa.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
⏲ 1 minute 17 seconds 👁 21
_dr-bendell-discusses-pembrolizumab-in-crc.webp "OncLiveTV")
_outcomes-of-first-line-pembrolizumab-monotherapy-for-pd-l1positive-metastatic-nsclc.jpg)
_keynote-224-improving-hcc-outcomes-with-pembrolizumab.jpg)
_pembrolizumab-for-ps2-patients-with-adv-nsclc-results-of-the-peps2-trial-bmic-067.jpg)
_keynote-966-pembrolizumab-gemcitabine-and-cisplatin-for-cca.jpg)
_keytruda-pembrolizumab-drug-rx-information.jpg)
_keynote-667-pembrolizumab-plus-copdac-28-for-high-risk-chl-with-slow-early-response-to-oepa.jpg)
_dr-bendell-discusses-pembrolizumab-in-crc.jpg)
![[+]](/images/menu.gif){kind=small}